首页 > 最新文献

Journal of Internal Medicine最新文献

英文 中文
Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care 评估初级保健中2型糖尿病患者代谢功能障碍相关脂肪变性肝病的患病率和严重程度
IF 9.2 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-16 DOI: 10.1111/joim.20103
Wile Balkhed, Martin Bergram, Fredrik Iredahl, Markus Holmberg, Carl Edin, Carl-Johan Carlhäll, Tino Ebbers, Pontus Henriksson, Christian Simonsson, Karin Rådholm, Gunnar Cedersund, Mikael Forsgren, Olof Dahlqvist Leinhard, Cecilia Jönsson, Peter Lundberg, Stergios Kechagias, Nils Dahlström, Patrik Nasr, Mattias Ekstedt

Background and aims

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has increased during the epidemic of obesity. Type 2 diabetes mellitus (T2DM) is associated with progressive MASLD. Therefore, many guidelines recommend screening for MASLD in patients with T2DM. Most studies in patients with MASLD have been conducted in specialist care. We investigated the prevalence and severity of MASLD in patients with T2DM from primary care.

Methods

Patients with T2DM were prospectively included from primary care facilities to undergo transient elastography with controlled attenuation parameter and whole-body magnetic resonance imaging (MRI) to assess liver fat, cardiac function, muscle composition, and distribution of body fat.

Results

Among 308 participants, 59% had MASLD, 7% had suspected advanced fibrosis (transient elastography ≥ 10 kPa), and 1.9% had cirrhosis. The mean age was 63.9 ± 8.1 years; 37% were female, with no differences between the MASLD and the non-MASLD groups. Participants with MASLD had greater body mass index (31.1 ± 4.4 vs. 27.4 ± 4.1 kg/m2, p < 0.001) and a higher prevalence of obesity (60% vs. 21%, p < 0.001). Obesity increased the risk of fibrotic MASLD eightfold, as confirmed by multivariable analysis. Participants with MASLD also had increased visceral and abdominal subcutaneous adipose tissue and muscle fat infiltration. On cardiac MRI, participants with MASLD had a lower left ventricular (LV) stroke volume index, a lower LV end-diastolic volume index, and an increased LV concentricity.

Conclusions

In this cohort of primary care patients with T2DM, 59% had MASLD, and 7% had suspected advanced fibrosis. Obesity was a strong predictor of fibrotic MASLD. MASLD was associated with alterations to the left ventricle and increased deposition of ectopic fat.

背景和目的:随着肥胖的流行,代谢功能障碍相关的脂肪变性肝病(MASLD)的患病率有所增加。2型糖尿病(T2DM)与进行性MASLD相关。因此,许多指南建议对T2DM患者进行MASLD筛查。大多数对MASLD患者的研究都是在专科护理中进行的。我们调查了初级保健中T2DM患者MASLD的患病率和严重程度。方法:前瞻性地从初级保健机构纳入T2DM患者,接受衰减参数可控的瞬时弹性成像和全身磁共振成像(MRI),以评估肝脏脂肪、心功能、肌肉组成和体脂分布。结果:308名参与者中,59%患有MASLD, 7%疑似晚期纤维化(瞬时弹性成像≥10 kPa), 1.9%患有肝硬化。平均年龄63.9±8.1岁;37%是女性,在MASLD组和非MASLD组之间没有差异。MASLD患者的体重指数更高(31.1±4.4 vs. 27.4±4.1 kg/m2, p)。结论:在该T2DM初级保健患者队列中,59%患有MASLD, 7%疑似晚期纤维化。肥胖是纤维化性MASLD的重要预测因子。MASLD与左心室改变和异位脂肪沉积增加有关。
{"title":"Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care","authors":"Wile Balkhed,&nbsp;Martin Bergram,&nbsp;Fredrik Iredahl,&nbsp;Markus Holmberg,&nbsp;Carl Edin,&nbsp;Carl-Johan Carlhäll,&nbsp;Tino Ebbers,&nbsp;Pontus Henriksson,&nbsp;Christian Simonsson,&nbsp;Karin Rådholm,&nbsp;Gunnar Cedersund,&nbsp;Mikael Forsgren,&nbsp;Olof Dahlqvist Leinhard,&nbsp;Cecilia Jönsson,&nbsp;Peter Lundberg,&nbsp;Stergios Kechagias,&nbsp;Nils Dahlström,&nbsp;Patrik Nasr,&nbsp;Mattias Ekstedt","doi":"10.1111/joim.20103","DOIUrl":"10.1111/joim.20103","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and aims</h3>\u0000 \u0000 <p>The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has increased during the epidemic of obesity. Type 2 diabetes mellitus (T2DM) is associated with progressive MASLD. Therefore, many guidelines recommend screening for MASLD in patients with T2DM. Most studies in patients with MASLD have been conducted in specialist care. We investigated the prevalence and severity of MASLD in patients with T2DM from primary care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Patients with T2DM were prospectively included from primary care facilities to undergo transient elastography with controlled attenuation parameter and whole-body magnetic resonance imaging (MRI) to assess liver fat, cardiac function, muscle composition, and distribution of body fat.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 308 participants, 59% had MASLD, 7% had suspected advanced fibrosis (transient elastography ≥ 10 kPa), and 1.9% had cirrhosis. The mean age was 63.9 ± 8.1 years; 37% were female, with no differences between the MASLD and the non-MASLD groups. Participants with MASLD had greater body mass index (31.1 ± 4.4 vs. 27.4 ± 4.1 kg/m<sup>2</sup>, <i>p </i>&lt; 0.001) and a higher prevalence of obesity (60% vs. 21%, <i>p</i> &lt; 0.001). Obesity increased the risk of fibrotic MASLD eightfold, as confirmed by multivariable analysis. Participants with MASLD also had increased visceral and abdominal subcutaneous adipose tissue and muscle fat infiltration. On cardiac MRI, participants with MASLD had a lower left ventricular (LV) stroke volume index, a lower LV end-diastolic volume index, and an increased LV concentricity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>In this cohort of primary care patients with T2DM, 59% had MASLD, and 7% had suspected advanced fibrosis. Obesity was a strong predictor of fibrotic MASLD. MASLD was associated with alterations to the left ventricle and increased deposition of ectopic fat.</p>\u0000 </section>\u0000 </div>","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 3","pages":"173-187"},"PeriodicalIF":9.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.20103","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144300781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective association between plasma amino acids and healthy aging in older adults 血浆氨基酸与老年人健康衰老的前瞻性关联
IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-12 DOI: 10.1111/joim.20105
Damián González-Beltrán, Humberto Yévenes-Briones, Alberto Lana, Juan Cárdenas-Valladolid, Miguel Ángel Salinero-Fort, Fernando Rodríguez-Artalejo, Esther Lopez-Garcia, Francisco Félix Caballero

Background

Most studies have compared plasma amino acids profiling across different age groups using a cross-sectional design, but no previous research has assessed the relationship between specific amino acid species and healthy aging.

Objectives

This study aims to explore the relationship between plasma concentrations of nine amino acids and healthy aging in an older Spanish population.

Methods

This longitudinal study uses data from the Seniors-ENRICA 2 Spanish cohort, which comprises community-dwelling individuals aged 65 and older. Plasma amino acid concentrations were measured at baseline and after a 5-year follow-up period (n = 859). Healthy aging has been defined as the delay on the onset of chronic conditions, optimal physical functioning, and no cognitive impairment. Multilevel mixed effect logistic models were used to examine the prospective association proposed, after adjusting for age, sex, socioeconomic status, and lifestyle behaviors.

Results

The baseline mean age of the participants was 70.9 years (standard deviation [SD] = 4.0), and 51.6% were men. In the fully adjusted models, lower plasma concentrations of alanine [odds ratios per 1-SD increase (95% confidence interval) = 0.78 (0.72, 0.86)], isoleucine [0.70 (0.63, 0.78)], leucine [0.78 (0.71, 0.86)], and valine [0.79 (0.71, 0.86)] were prospectively associated with healthy aging (p-value < 0.001 in all cases). No significant associations were observed for glutamine, glycine, histidine, and aromatic amino acids.

Conclusion

Lower concentrations of alanine and branched-chain amino acids were prospectively associated with healthy aging in the older population.

背景:大多数研究使用横断面设计比较了不同年龄组的血浆氨基酸谱,但之前没有研究评估特定氨基酸种类与健康衰老之间的关系。目的:本研究旨在探讨西班牙老年人群中9种氨基酸的血浆浓度与健康老龄化之间的关系。方法:这项纵向研究使用了来自senior - enrica 2西班牙队列的数据,该队列包括65岁及以上的社区居民。在基线和5年随访期后测定血浆氨基酸浓度(n = 859)。健康的老龄化被定义为慢性疾病的延迟发作,最佳的身体功能,没有认知障碍。在调整了年龄、性别、社会经济地位和生活方式行为后,采用多层次混合效应逻辑模型来检验提出的前瞻性关联。结果:参与者的基线平均年龄为70.9岁(标准差[SD] = 4.0), 51.6%为男性。在完全调整后的模型中,较低的血浆丙氨酸浓度[每增加1-SD的比值比(95%置信区间)= 0.78(0.72,0.86)]、异亮氨酸[0.70(0.63,0.78)]、亮氨酸[0.78(0.71,0.86)]和缬氨酸[0.79(0.71,0.86)]与健康老龄化有前瞻性关联(p值结论:较低的丙氨酸和支链氨基酸浓度与老年人群健康老龄化有前瞻性关联。
{"title":"Prospective association between plasma amino acids and healthy aging in older adults","authors":"Damián González-Beltrán,&nbsp;Humberto Yévenes-Briones,&nbsp;Alberto Lana,&nbsp;Juan Cárdenas-Valladolid,&nbsp;Miguel Ángel Salinero-Fort,&nbsp;Fernando Rodríguez-Artalejo,&nbsp;Esther Lopez-Garcia,&nbsp;Francisco Félix Caballero","doi":"10.1111/joim.20105","DOIUrl":"10.1111/joim.20105","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Most studies have compared plasma amino acids profiling across different age groups using a cross-sectional design, but no previous research has assessed the relationship between specific amino acid species and healthy aging.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This study aims to explore the relationship between plasma concentrations of nine amino acids and healthy aging in an older Spanish population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This longitudinal study uses data from the Seniors-ENRICA 2 Spanish cohort, which comprises community-dwelling individuals aged 65 and older. Plasma amino acid concentrations were measured at baseline and after a 5-year follow-up period (<i>n</i> = 859). Healthy aging has been defined as the delay on the onset of chronic conditions, optimal physical functioning, and no cognitive impairment. Multilevel mixed effect logistic models were used to examine the prospective association proposed, after adjusting for age, sex, socioeconomic status, and lifestyle behaviors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The baseline mean age of the participants was 70.9 years (standard deviation [SD] = 4.0), and 51.6% were men. In the fully adjusted models, lower plasma concentrations of alanine [odds ratios per 1-SD increase (95% confidence interval) = 0.78 (0.72, 0.86)], isoleucine [0.70 (0.63, 0.78)], leucine [0.78 (0.71, 0.86)], and valine [0.79 (0.71, 0.86)] were prospectively associated with healthy aging (<i>p</i>-value &lt; 0.001 in all cases). No significant associations were observed for glutamine, glycine, histidine, and aromatic amino acids.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Lower concentrations of alanine and branched-chain amino acids were prospectively associated with healthy aging in the older population.</p>\u0000 </section>\u0000 </div>","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 2","pages":"123-134"},"PeriodicalIF":9.0,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.20105","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144273796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No association between sleep apnea, nocturnal blood pressure dipping, and cognitive performance among Swedish adults aged 50–65 years 在50-65岁的瑞典成年人中,睡眠呼吸暂停、夜间血压下降和认知表现之间没有关联。
IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-12 DOI: 10.1111/joim.20104
Xiao Tan, Mirjam Ljunggren, Johan Sundström, Eva Lindberg
<p>Dear Editor,</p><p>Repeated breathing disruptions in obstructive sleep apnea (OSA) result in reduced oxygen supply to the brain and sleep deprivation. Previous studies have indicated that OSA is associated with impairments in several cognitive domains, including attention, executive function, and information processing speed [<span>1, 2</span>]. This may be explained by the neurological damage caused by intermittent hypoxia, as executive function and reaction time are thought to be related to the severity of hypoxemia [<span>2</span>]. However, a clinical trial has reported that continuous positive airway pressure treatment resulted in only mild and transient improvement in executive and frontal-lobe function in severe OSA, but not in mild or moderate OSA [<span>3</span>]. This may be attributed to factors related to study design and participant selection, leading to a relatively low susceptibility to the neurocognitive effects of OSA and a reduced response to treatment, but it may also suggest the involvement of other underlying mechanisms. Normally, blood pressure (BP) decreases at nighttime, a phenomenon known as nocturnal BP dipping. However, when BP fails to decrease adequately or even increases, this is termed reduced or reverse dipping [<span>4</span>]. Results from a longitudinal study revealed that less nocturnal BP dipping was associated with worse cognitive function, especially executive function [<span>5</span>]. Reduced and reversed nocturnal BP dipping are particularly common among individuals with OSA [<span>6</span>], highlighting a potentially mediating effect of BP dipping in the association between sleep apnea and cognitive impairment.</p><p>Therefore, we aimed to determine the relationship between OSA and cognitive impairment and explore the potential mediation of this relationship by reverse BP dipping. We analyzed data from the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS), a random sample of adults aged 50–64 years. The details of this cohort study are provided in the Supporting Information. In this study, we included 2973 participants with complete data on overnight sleep breathing measurements, 24-h ambulatory BP monitoring (ABPM), the Trail Making Test Part B (TMT-B), and relevant covariates. OSA was quantified by the Apnea–Hypopnea Index (AHI). Cognitive function was assessed by TMT-B, a timed executive function task requiring rapid alternation between connecting numbered and lettered circles, during the day after the overnight sleep breathing measurement [<span>7</span>]. Classification of AHI, ABPM parameters, category of dippers, and TMT-B details are provided in the Supporting Information. To explore the dose–response association between severity of OSA or BP dipping and TMT-B, restricted cubic spline models with three knots (at the 5th, 50th, and 95th percentiles) were performed, adjusting for age, sex, BMI, alcohol consumption, and smoking.</p><p>Characteristics of the study population by sev
亲爱的编辑,阻塞性睡眠呼吸暂停(OSA)患者反复呼吸中断会导致大脑供氧减少和睡眠剥夺。先前的研究表明,OSA与几个认知领域的损伤有关,包括注意力、执行功能和信息处理速度[1,2]。这可能是由于间歇性缺氧引起的神经损伤,因为执行功能和反应时间被认为与低氧血症的严重程度有关。然而,一项临床试验报道,持续气道正压治疗仅导致重度OSA患者执行和额叶功能轻度和短暂性改善,而对轻度或中度OSA患者则没有改善。这可能归因于与研究设计和参与者选择相关的因素,导致OSA对神经认知影响的易感性相对较低,对治疗的反应较低,但也可能涉及其他潜在机制。正常情况下,血压(BP)在夜间下降,这种现象被称为夜间血压下降。然而,当BP不能充分降低甚至增加时,这被称为降低或反向倾斜[4]。一项纵向研究的结果显示,夜间血压下降较少与认知功能,尤其是执行功能较差有关。夜间血压下降的减少和逆转在阻塞性睡眠呼吸暂停患者中尤为常见,这表明血压下降在睡眠呼吸暂停和认知障碍之间具有潜在的中介作用。因此,我们旨在确定OSA与认知功能障碍之间的关系,并探讨反向血压下降在这一关系中的潜在中介作用。我们分析了基于人群的瑞典心肺生物图像研究(SCAPIS)的数据,该研究随机抽样了50-64岁的成年人。本队列研究的详细信息见辅助信息。在这项研究中,我们纳入了2973名参与者,他们的数据完整,包括夜间睡眠呼吸测量、24小时动态血压监测(ABPM)、造径测试B部分(TMT-B)和相关的变量。采用呼吸暂停低通气指数(AHI)对OSA进行量化。在夜间睡眠呼吸测量[7]后的第二天,通过TMT-B评估认知功能,TMT-B是一项定时执行功能任务,要求在连接数字和字母的圆圈之间快速交替。AHI分类、ABPM参数、倾角分类和TMT-B详细信息见支持信息。为了探讨OSA或血压下降严重程度与TMT-B之间的剂量-反应关系,采用三节(第5、50和95个百分点)的限制性三次样条模型,调整年龄、性别、BMI、饮酒和吸烟。按OSA严重程度划分的研究人群特征见表S1。在所有参与者中,43%的人患有OSA (AHI≥5事件/小时),14%的人患有中至重度OSA (AHI≥15事件/小时),4%的人患有重度OSA (AHI &gt;30事件/ h)。在调整潜在混杂因素后,我们观察到TMT-B评估的OSA和认知表现之间没有独立的关联(AHI p = 0.599, ODI p = 0.335)(图1a)。睡眠/清醒收缩压下降比、睡眠/清醒舒张压下降比和认知表现之间没有关联(舒张压下降比p = 0.077,收缩压下降比p = 0.410,图1b)。我们的分析显示,当考虑重要的混杂因素时,AHI和odi都与TMT-B评估的认知表现无关。这与之前的研究一致,该研究也发现睡眠呼吸障碍与TMT-B表现之间没有显著关联。然而,我们的研究结果与最近在美国成年人中进行的一项研究结果相反,该研究报告称,轻度至重度OSA与较差的全球认知bbb相关。这可能是使用单一认知测试的局限性,它可能不够敏感,无法检测出OSA和认知功能之间的潜在关联。此外,我们研究的参与者相对于之前将OSA与认知障碍联系起来的研究中的参与者更年轻。此外,与之前使用Stroop测试(一种评估额叶执行功能的工具)进行的纵向研究不同,我们在我们的人群中观察到夜间血压下降模式与认知表现之间没有关联,这与在中老年人群中使用TMT-B测试的研究一致。这种差异可能是由于评估重点的不同,因为两种测试评估执行功能的侧重点不同。这也可能表明血压调节和大脑健康之间存在复杂的相互作用,而这种相互作用不能仅通过浸入模式完全捕捉到。 此外,横断面设计限制了因果推理,OSA、倾斜模式和认知之间的不显著趋势可能是由于有限的功率。未来的研究可以通过更大的队列或纵向设计和全面的认知测试来探索OSA与认知功能障碍的关系以及反向血压下降的潜在中介作用。作者不存在与本研究相关的利益冲突。
{"title":"No association between sleep apnea, nocturnal blood pressure dipping, and cognitive performance among Swedish adults aged 50–65 years","authors":"Xiao Tan,&nbsp;Mirjam Ljunggren,&nbsp;Johan Sundström,&nbsp;Eva Lindberg","doi":"10.1111/joim.20104","DOIUrl":"10.1111/joim.20104","url":null,"abstract":"&lt;p&gt;Dear Editor,&lt;/p&gt;&lt;p&gt;Repeated breathing disruptions in obstructive sleep apnea (OSA) result in reduced oxygen supply to the brain and sleep deprivation. Previous studies have indicated that OSA is associated with impairments in several cognitive domains, including attention, executive function, and information processing speed [&lt;span&gt;1, 2&lt;/span&gt;]. This may be explained by the neurological damage caused by intermittent hypoxia, as executive function and reaction time are thought to be related to the severity of hypoxemia [&lt;span&gt;2&lt;/span&gt;]. However, a clinical trial has reported that continuous positive airway pressure treatment resulted in only mild and transient improvement in executive and frontal-lobe function in severe OSA, but not in mild or moderate OSA [&lt;span&gt;3&lt;/span&gt;]. This may be attributed to factors related to study design and participant selection, leading to a relatively low susceptibility to the neurocognitive effects of OSA and a reduced response to treatment, but it may also suggest the involvement of other underlying mechanisms. Normally, blood pressure (BP) decreases at nighttime, a phenomenon known as nocturnal BP dipping. However, when BP fails to decrease adequately or even increases, this is termed reduced or reverse dipping [&lt;span&gt;4&lt;/span&gt;]. Results from a longitudinal study revealed that less nocturnal BP dipping was associated with worse cognitive function, especially executive function [&lt;span&gt;5&lt;/span&gt;]. Reduced and reversed nocturnal BP dipping are particularly common among individuals with OSA [&lt;span&gt;6&lt;/span&gt;], highlighting a potentially mediating effect of BP dipping in the association between sleep apnea and cognitive impairment.&lt;/p&gt;&lt;p&gt;Therefore, we aimed to determine the relationship between OSA and cognitive impairment and explore the potential mediation of this relationship by reverse BP dipping. We analyzed data from the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS), a random sample of adults aged 50–64 years. The details of this cohort study are provided in the Supporting Information. In this study, we included 2973 participants with complete data on overnight sleep breathing measurements, 24-h ambulatory BP monitoring (ABPM), the Trail Making Test Part B (TMT-B), and relevant covariates. OSA was quantified by the Apnea–Hypopnea Index (AHI). Cognitive function was assessed by TMT-B, a timed executive function task requiring rapid alternation between connecting numbered and lettered circles, during the day after the overnight sleep breathing measurement [&lt;span&gt;7&lt;/span&gt;]. Classification of AHI, ABPM parameters, category of dippers, and TMT-B details are provided in the Supporting Information. To explore the dose–response association between severity of OSA or BP dipping and TMT-B, restricted cubic spline models with three knots (at the 5th, 50th, and 95th percentiles) were performed, adjusting for age, sex, BMI, alcohol consumption, and smoking.&lt;/p&gt;&lt;p&gt;Characteristics of the study population by sev","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 2","pages":"135-137"},"PeriodicalIF":9.0,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.20104","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144273795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The future of healthcare-associated infection surveillance: Automated surveillance and using the potential of artificial intelligence 医疗保健相关感染监测的未来:自动化监测和利用人工智能的潜力。
IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-05 DOI: 10.1111/joim.20100
Suzanne D. van der Werff, Stephanie M. van Rooden, Aron Henriksson, Michael Behnke, Seven J. S. Aghdassi, Maaike S. M. van Mourik, Pontus Nauclér

Healthcare-associated infections (HAIs) are common adverse events, and surveillance is considered a core component of effective HAI reduction programmes. Recently, efforts have focused on automating the traditional manual surveillance process by utilizing data from electronic health record (EHR) systems. Using EHR data for automated surveillance, algorithms have been developed to identify patients with (ventilator-associated) pneumonia and (catheter-related) bloodstream, surgical site, (catheter-associated) urinary tract and Clostridioides difficile infections (sensitivity 54.2%–100%, specificity 63.5%–100%). Mostly methods based on natural language processing have been applied to extract information from unstructured clinical information. Further developments in artificial intelligence (AI), such as large language models, are expected to support and improve different aspects within the surveillance process; for example, more precise identification of patients with HAI. However, AI-based methods have been applied less frequently in automated surveillance and more frequently for (early) prediction, particularly for sepsis. Despite heterogeneity in settings, populations, definitions and model designs, AI-based models have shown promising results, with moderate to very good performance (accuracy 61%–99%) and predicted sepsis within 0–40 h before onset. AI-based prediction models detecting patients at risk of developing different HAIs should be explored further. The continuous evolution of AI and automation will transform HAI surveillance and prediction, offering more objective and timely infection rates and predictions. The implementation of (AI-supported) automated surveillance and prediction systems for HAI in daily practice remains scarce. Successful development and implementation of these systems demand meeting requirements related to technical capabilities, governance, practical and regulatory considerations and quality monitoring.

卫生保健相关感染是常见的不良事件,监测被认为是有效减少卫生保健相关感染规划的核心组成部分。最近,人们致力于通过利用电子健康记录(EHR)系统的数据来自动化传统的人工监测过程。利用电子病历数据进行自动监测,已经开发出算法来识别(呼吸机相关)肺炎和(导管相关)血流、手术部位、(导管相关)尿路和艰难梭菌感染患者(敏感性54.2%-100%,特异性63.5%-100%)。从非结构化的临床信息中提取信息,多采用基于自然语言处理的方法。人工智能(AI)的进一步发展,如大型语言模型,预计将支持和改进监测过程中的不同方面;例如,更精确地识别HAI患者。然而,基于人工智能的方法在自动化监测中的应用较少,而更频繁地用于(早期)预测,特别是败血症。尽管环境、人群、定义和模型设计存在异质性,但基于人工智能的模型显示出有希望的结果,具有中等至非常好的性能(准确率为61%-99%),并能在发病前0-40小时内预测败血症。基于人工智能的预测模型检测不同HAIs风险的患者还有待进一步探索。人工智能和自动化的不断发展将改变HAI的监测和预测,提供更客观和及时的感染率和预测。在日常实践中实施(人工智能支持的)HAI自动监测和预测系统仍然很少。这些系统的成功开发和实施需要满足与技术能力、治理、实践和法规考虑以及质量监控相关的需求。
{"title":"The future of healthcare-associated infection surveillance: Automated surveillance and using the potential of artificial intelligence","authors":"Suzanne D. van der Werff,&nbsp;Stephanie M. van Rooden,&nbsp;Aron Henriksson,&nbsp;Michael Behnke,&nbsp;Seven J. S. Aghdassi,&nbsp;Maaike S. M. van Mourik,&nbsp;Pontus Nauclér","doi":"10.1111/joim.20100","DOIUrl":"10.1111/joim.20100","url":null,"abstract":"<p>Healthcare-associated infections (HAIs) are common adverse events, and surveillance is considered a core component of effective HAI reduction programmes. Recently, efforts have focused on automating the traditional manual surveillance process by utilizing data from electronic health record (EHR) systems. Using EHR data for automated surveillance, algorithms have been developed to identify patients with (ventilator-associated) pneumonia and (catheter-related) bloodstream, surgical site, (catheter-associated) urinary tract and <i>Clostridioides difficile</i> infections (sensitivity 54.2%–100%, specificity 63.5%–100%). Mostly methods based on natural language processing have been applied to extract information from unstructured clinical information. Further developments in artificial intelligence (AI), such as large language models, are expected to support and improve different aspects within the surveillance process; for example, more precise identification of patients with HAI. However, AI-based methods have been applied less frequently in automated surveillance and more frequently for (early) prediction, particularly for sepsis. Despite heterogeneity in settings, populations, definitions and model designs, AI-based models have shown promising results, with moderate to very good performance (accuracy 61%–99%) and predicted sepsis within 0–40 h before onset. AI-based prediction models detecting patients at risk of developing different HAIs should be explored further. The continuous evolution of AI and automation will transform HAI surveillance and prediction, offering more objective and timely infection rates and predictions. The implementation of (AI-supported) automated surveillance and prediction systems for HAI in daily practice remains scarce. Successful development and implementation of these systems demand meeting requirements related to technical capabilities, governance, practical and regulatory considerations and quality monitoring.</p>","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 2","pages":"54-77"},"PeriodicalIF":9.0,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.20100","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144223862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preexisting symptoms increase the risk of developing long COVID during the SARS-CoV-2 pandemic 在SARS-CoV-2大流行期间,先前存在的症状增加了患长期COVID的风险。
IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-04 DOI: 10.1111/joim.20102
Vincent Lak, Helen Sjöland, Martin Adiels, Christina E. Lundberg, Josefina Robertson, Maria Åberg, Christian Alex, Martin Lindgren, Annika Rosengren

Background

Long COVID is defined as otherwise unexplained symptoms following a SARS-CoV-2 infection.

Objective

To examine the prevalence of preexisting symptoms compatible with long COVID in individuals with a diagnosis of long COVID.

Methods

This retrospective, observational study included the adult population (aged 18 years and older) in Region Västra Götaland, with at least one recorded healthcare contact between January 1, 2020, and November 30, 2023, from a regional database comprising all levels of healthcare contacts. Data on long COVID, relevant symptoms before and after the pandemic started (2016–2023), and SARS-CoV-2 infection status were extracted using the International Classification of Diseases version 10 (ICD-10) codes. Individuals who had been hospitalized due to a SARS-CoV-2 infection were considered separately.

Results

Out of 1,415,885 individuals, 9202 (0.6%) had been diagnosed with long COVID. Among the non-hospitalized individuals, the record of at least one of the relevant symptoms was more common in those with long COVID compared to those without it (57.6% vs. 36.3% for men and 71.6% vs. 50.4% for women), already before January 1, 2020. Among individuals with any relevant symptom, the odds ratios (ORs) of having long COVID were OR = 2.28 (95% confidence interval [CI] = 2.10–2.48) for men and OR = 2.32 (95% CI = 2.18–2.48 for women) after adjusting for age group, obesity, asthma, and anxiety, compared with individuals without any relevant symptom.

Conclusions

Individuals diagnosed with long COVID had more healthcare contacts for relevant symptoms even before the pandemic compared to individuals without long COVID.

背景:长COVID被定义为SARS-CoV-2感染后无法解释的症状。目的:探讨长冠状病毒感染患者既往存在长冠状病毒感染相关症状的发生率。方法:这项回顾性观察性研究包括Västra Götaland地区的成年人口(18岁及以上),在2020年1月1日至2023年11月30日期间至少有一个记录在案的卫生保健接触者,这些接触者来自包括各级卫生保健接触者的区域数据库。使用国际疾病分类第10版(ICD-10)代码提取长冠状病毒、大流行开始前后(2016-2023年)的相关症状以及SARS-CoV-2感染状态的数据。因SARS-CoV-2感染而住院的个体被单独考虑。结果:1415885例中,9202例(0.6%)被诊断为长冠状病毒。在未住院的人群中,在2020年1月1日之前,长冠肺炎患者中至少有一种相关症状的记录比没有长冠肺炎的人更常见(男性为57.6%对36.3%,女性为71.6%对50.4%)。在有任何相关症状的个体中,与没有任何相关症状的个体相比,在调整了年龄组、肥胖、哮喘和焦虑等因素后,男性患长期COVID的比值比(OR)为OR = 2.28(95%可信区间[CI] = 2.10-2.48),女性为OR = 2.32 (95% CI = 2.18-2.48)。结论:与没有长冠状病毒的个体相比,被诊断为长冠状病毒的个体在大流行之前就有更多的相关症状的医疗接触。
{"title":"Preexisting symptoms increase the risk of developing long COVID during the SARS-CoV-2 pandemic","authors":"Vincent Lak,&nbsp;Helen Sjöland,&nbsp;Martin Adiels,&nbsp;Christina E. Lundberg,&nbsp;Josefina Robertson,&nbsp;Maria Åberg,&nbsp;Christian Alex,&nbsp;Martin Lindgren,&nbsp;Annika Rosengren","doi":"10.1111/joim.20102","DOIUrl":"10.1111/joim.20102","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Long COVID is defined as otherwise unexplained symptoms following a SARS-CoV-2 infection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To examine the prevalence of preexisting symptoms compatible with long COVID in individuals with a diagnosis of long COVID.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective, observational study included the adult population (aged 18 years and older) in Region Västra Götaland, with at least one recorded healthcare contact between January 1, 2020, and November 30, 2023, from a regional database comprising all levels of healthcare contacts. Data on long COVID, relevant symptoms before and after the pandemic started (2016–2023), and SARS-CoV-2 infection status were extracted using the International Classification of Diseases version 10 (ICD-10) codes. Individuals who had been hospitalized due to a SARS-CoV-2 infection were considered separately.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Out of 1,415,885 individuals, 9202 (0.6%) had been diagnosed with long COVID. Among the non-hospitalized individuals, the record of at least one of the relevant symptoms was more common in those with long COVID compared to those without it (57.6% vs. 36.3% for men and 71.6% vs. 50.4% for women), already before January 1, 2020. Among individuals with any relevant symptom, the odds ratios (ORs) of having long COVID were OR = 2.28 (95% confidence interval [CI] = 2.10–2.48) for men and OR = 2.32 (95% CI = 2.18–2.48 for women) after adjusting for age group, obesity, asthma, and anxiety, compared with individuals without any relevant symptom.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Individuals diagnosed with long COVID had more healthcare contacts for relevant symptoms even before the pandemic compared to individuals without long COVID.</p>\u0000 </section>\u0000 </div>","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 2","pages":"107-122"},"PeriodicalIF":9.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.20102","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144214410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dad's legacy: Epigenetic reprogramming and paternal inflammatory memory in offspring health 父亲的遗产:表观遗传重编程和后代健康中的父亲炎症记忆。
IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-29 DOI: 10.1111/joim.20094
Shamila D. Alipoor, Parisa Norouzitallab, Anita Öst, Maria Lerm

Over the past decade, numerous reports have highlighted intergenerational and even transgenerational epigenetic effects resulting from parental exposure to diets, toxins, and stress. In many cases, these parentally induced phenotypes do not seem to confer an obvious benefit, making it challenging to understand the evolutionary drivers behind them. In this perspective, we discuss recent observations in humans and rodents indicating that a parental infection or vaccination can enhance the offspring's ability to cope with infections. Such parental priming of their offspring's immune system and cellular defense would provide immediate protection to the newborn, offering a clear evolutionary advantage. Here, focusing mainly on paternal effects, we propose that a parentally induced inflammatory memory in the offspring could be the underlying mechanism for many of the reported inter- and transgenerational effects. Sperm-borne RNA could be a triggering signal to initiate inflammatory pathways in early embryogenesis. This gene-regulatory state would then be maintained via epigenetic mechanisms throughout each mitosis and last for the individual's lifetime. The accumulating understanding that diet, stress, toxins, and infections affect offspring health raises important questions about public health policies. There is an urgent need to understand what consequences different exposures during sensitive time windows have on future generations.

在过去的十年里,许多报告都强调了由父母暴露于饮食、毒素和压力造成的代际甚至跨代表观遗传效应。在许多情况下,这些父母诱导的表型似乎并没有带来明显的好处,这使得理解它们背后的进化驱动因素变得具有挑战性。从这个角度来看,我们讨论了最近对人类和啮齿动物的观察结果,表明父母感染或接种疫苗可以增强后代应对感染的能力。这种父母对后代免疫系统和细胞防御的启动将为新生儿提供即时保护,提供明显的进化优势。在这里,我们主要关注父亲的影响,我们提出父母在后代中诱导的炎症记忆可能是许多报道的跨代和跨代影响的潜在机制。精子携带的RNA可能是启动早期胚胎发生炎症途径的触发信号。这种基因调控状态将通过表观遗传机制在每次有丝分裂中维持,并持续个体的一生。人们对饮食、压力、毒素和感染影响后代健康的认识不断积累,这引发了有关公共卫生政策的重要问题。迫切需要了解在敏感时间窗期间不同的暴露对后代的影响。
{"title":"Dad's legacy: Epigenetic reprogramming and paternal inflammatory memory in offspring health","authors":"Shamila D. Alipoor,&nbsp;Parisa Norouzitallab,&nbsp;Anita Öst,&nbsp;Maria Lerm","doi":"10.1111/joim.20094","DOIUrl":"10.1111/joim.20094","url":null,"abstract":"<p>Over the past decade, numerous reports have highlighted intergenerational and even transgenerational epigenetic effects resulting from parental exposure to diets, toxins, and stress. In many cases, these parentally induced phenotypes do not seem to confer an obvious benefit, making it challenging to understand the evolutionary drivers behind them. In this perspective, we discuss recent observations in humans and rodents indicating that a parental infection or vaccination can enhance the offspring's ability to cope with infections. Such parental priming of their offspring's immune system and cellular defense would provide immediate protection to the newborn, offering a clear evolutionary advantage. Here, focusing mainly on paternal effects, we propose that a parentally induced inflammatory memory in the offspring could be the underlying mechanism for many of the reported inter- and transgenerational effects. Sperm-borne RNA could be a triggering signal to initiate inflammatory pathways in early embryogenesis. This gene-regulatory state would then be maintained via epigenetic mechanisms throughout each mitosis and last for the individual's lifetime. The accumulating understanding that diet, stress, toxins, and infections affect offspring health raises important questions about public health policies. There is an urgent need to understand what consequences different exposures during sensitive time windows have on future generations.</p>","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 1","pages":"16-30"},"PeriodicalIF":9.0,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.20094","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144172161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teaching Gentle Medicine 温和医学教学。
IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-29 DOI: 10.1111/joim.20101
Benjamin Chin-Yee, Ezio Laconi, Jacob Stegenga
{"title":"Teaching Gentle Medicine","authors":"Benjamin Chin-Yee,&nbsp;Ezio Laconi,&nbsp;Jacob Stegenga","doi":"10.1111/joim.20101","DOIUrl":"10.1111/joim.20101","url":null,"abstract":"","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 2","pages":"143-144"},"PeriodicalIF":9.0,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.20101","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144172167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors reply: Six-fold increased risk of acute pancreatitis in alcohol-related liver disease compared to matched comparators 作者回复:与匹配的比较者相比,酒精相关肝病的急性胰腺炎风险增加了6倍。
IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-25 DOI: 10.1111/joim.20097
Ana Dugic, Hannes Hagström
{"title":"Authors reply: Six-fold increased risk of acute pancreatitis in alcohol-related liver disease compared to matched comparators","authors":"Ana Dugic,&nbsp;Hannes Hagström","doi":"10.1111/joim.20097","DOIUrl":"10.1111/joim.20097","url":null,"abstract":"","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 1","pages":"51-52"},"PeriodicalIF":9.0,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144140872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regarding: Sixfold increased risk of acute pancreatitis in alcohol-related liver disease compared to matched comparators 关于:与匹配的比较者相比,酒精相关肝病的急性胰腺炎风险增加6倍。
IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-25 DOI: 10.1111/joim.20096
Shih-Wei Lai, Kuan-Fu Liao
{"title":"Regarding: Sixfold increased risk of acute pancreatitis in alcohol-related liver disease compared to matched comparators","authors":"Shih-Wei Lai,&nbsp;Kuan-Fu Liao","doi":"10.1111/joim.20096","DOIUrl":"10.1111/joim.20096","url":null,"abstract":"","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 1","pages":"49-50"},"PeriodicalIF":9.0,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144140874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing early detection of cognitive impairment in primary care to improve care for older adults 在初级保健中实施认知障碍的早期检测,以改善对老年人的护理。
IF 9 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-23 DOI: 10.1111/joim.20098
Nicole R. Fowler, Katherine A. Partrick, James Taylor, Michael Hornbecker, Kevin Kelleher, Malaz Boustani, Jeffrey L. Cummings, Tim MacLeod, Michelle M. Mielke, Jared R. Brosch, Janice Lee, Eli Shobin, James E. Galvin, Howard Fillit, Chinedu Udeh-Momoh, Deanna R. Willis

Primary care is the ideal setting for early detection of mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD), as it serves as the primary point of care for most older adults. With the growing aging population, reliance on specialists for detection and diagnosis is unsustainable, highlighting the need for primary care-led assessment. Recent research findings on successful brain health prevention strategies, AD diagnostic tools, and anti-amyloid treatments empower primary care to play a central role in early detection and intervention. Primary care-focused resources are being developed, including tools for cognitive assessments and materials designed to educate patients about brain health and initiate discussions on lifestyle modifications, thereby making early detection more feasible and efficient. Identifying risk factors early enables providers to implement interventions that can slow cognitive decline and improve outcomes for patients and caregivers. If left undetected and unmanaged, MCI and ADRD can lead to worse outcomes, including increased falls, hospitalizations, financial vulnerability, and caregiver stress. Early detection enables the identification of reversible causes of cognitive impairment, supports the management of comorbidities worsened by cognitive decline, mitigates safety risks, and can preserve quality of life. Importantly, primary care is essential for addressing ADRD-related health disparities that disproportionately affect racial minorities, rural populations, and those of lower socioeconomic status. With a focus on the United States healthcare system, this perspective addresses how implementing early detection practices into primary care can improve outcomes for patients and caregivers, reduce societal burdens, and promote health equity in ADRD care.

初级保健是早期发现轻度认知障碍(MCI)和阿尔茨海默病及相关痴呆(ADRD)的理想场所,因为它是大多数老年人的主要护理点。随着人口日益老龄化,依靠专家进行检测和诊断是不可持续的,这突出了以初级保健为主导的评估的必要性。最近关于成功的脑健康预防策略、AD诊断工具和抗淀粉样蛋白治疗的研究成果使初级保健在早期发现和干预中发挥核心作用。目前正在开发以初级保健为重点的资源,包括认知评估工具和旨在教育患者有关大脑健康的材料,并发起关于改变生活方式的讨论,从而使早期发现更加可行和有效。早期识别风险因素使提供者能够实施干预措施,减缓认知能力下降,改善患者和护理人员的预后。如果不及时发现和管理,轻度认知损伤和ADRD会导致更糟糕的结果,包括跌倒、住院、经济脆弱性和照顾者压力的增加。早期发现可以识别认知障碍的可逆原因,支持管理因认知能力下降而恶化的合并症,减轻安全风险,并可以保持生活质量。重要的是,初级保健对于解决与adrd相关的健康差异至关重要,这种差异不成比例地影响少数种族、农村人口和社会经济地位较低的人群。以美国的医疗保健系统为重点,本观点探讨了如何在初级保健中实施早期发现实践,以改善患者和护理人员的结果,减轻社会负担,促进ADRD护理中的健康公平。
{"title":"Implementing early detection of cognitive impairment in primary care to improve care for older adults","authors":"Nicole R. Fowler,&nbsp;Katherine A. Partrick,&nbsp;James Taylor,&nbsp;Michael Hornbecker,&nbsp;Kevin Kelleher,&nbsp;Malaz Boustani,&nbsp;Jeffrey L. Cummings,&nbsp;Tim MacLeod,&nbsp;Michelle M. Mielke,&nbsp;Jared R. Brosch,&nbsp;Janice Lee,&nbsp;Eli Shobin,&nbsp;James E. Galvin,&nbsp;Howard Fillit,&nbsp;Chinedu Udeh-Momoh,&nbsp;Deanna R. Willis","doi":"10.1111/joim.20098","DOIUrl":"10.1111/joim.20098","url":null,"abstract":"<p>Primary care is the ideal setting for early detection of mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD), as it serves as the primary point of care for most older adults. With the growing aging population, reliance on specialists for detection and diagnosis is unsustainable, highlighting the need for primary care-led assessment. Recent research findings on successful brain health prevention strategies, AD diagnostic tools, and anti-amyloid treatments empower primary care to play a central role in early detection and intervention. Primary care-focused resources are being developed, including tools for cognitive assessments and materials designed to educate patients about brain health and initiate discussions on lifestyle modifications, thereby making early detection more feasible and efficient. Identifying risk factors early enables providers to implement interventions that can slow cognitive decline and improve outcomes for patients and caregivers. If left undetected and unmanaged, MCI and ADRD can lead to worse outcomes, including increased falls, hospitalizations, financial vulnerability, and caregiver stress. Early detection enables the identification of reversible causes of cognitive impairment, supports the management of comorbidities worsened by cognitive decline, mitigates safety risks, and can preserve quality of life. Importantly, primary care is essential for addressing ADRD-related health disparities that disproportionately affect racial minorities, rural populations, and those of lower socioeconomic status. With a focus on the United States healthcare system, this perspective addresses how implementing early detection practices into primary care can improve outcomes for patients and caregivers, reduce societal burdens, and promote health equity in ADRD care.</p>","PeriodicalId":196,"journal":{"name":"Journal of Internal Medicine","volume":"298 1","pages":"31-45"},"PeriodicalIF":9.0,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/joim.20098","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144136101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1